Rainbow Childrens Medicare Ltd Q1 FY27 Results Analysis: Revenue Surges 33%, Margin Compresses 71 bps

Rainbow Childrens Medicare Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 469.99 Cr (+33.17% YoY) and PAT growth of +13.22% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Consolidated revenue grew 33% YoY, powered by acquisitions that added Rs.41 Cr in revenue. However, EBITDA margin compressed 71 bps YoY and PAT-owners growth lagged revenue significantly, with standalone PAT nearly flat. New hospital expansions in Mumbai and Nellore provide future catalysts but near-term margin pressure persists.

Key Investment Insights

Key Positives

• Consolidated revenue grew 33.17% YoY to Rs.469.99 Cr, with organic standalone growth of 22.64%.
• Subsidiary revenue contribution from acquisitions jumped from Rs.18.18 Cr to Rs.59.44 Cr, reflecting successful integration.
• EBITDA grew 29.94% YoY to Rs.134.65 Cr.
• EPS grew 13.28% YoY to Rs.5.97.

Risk Factors

• EBITDA margin compressed 71 bps YoY to 28.65% and 248 bps QoQ, indicating cost pressure.
• PAT-owners growth (13.22%) significantly lagged revenue growth (33.17%), reflecting margin erosion.
• Standalone PAT grew only 1.91% YoY, showing organic profitability weakness.
• Professional fees to doctors grew faster than revenue QoQ (+9.89% vs +2.19%), pressuring margins.
• No FY27 forward guidance provided, reducing visibility on future trajectory.